A Recovery That Is Priced, Not Packed
What strikes us about the numbers is how unevenly the post-pandemic rebound is being distributed. Asia-Pacific, per PwC, is expected to grow from $13.8 billion in 2025 to approximately $17 billion by 2030 — a 4.3% CAGR that places the region firmly at the head of the parade. EMEA follows at 3.3% CAGR, expanding from $8.6 billion to roughly $10.1 billion, while North America trails at 2.8%, moving from $8.7 billion to about $9.9 billion. The report makes plain an uncomfortable truth cinephiles have long suspected: admissions globally are projected to rise at only a 1% CAGR. The growth, in other words, is being priced in rather than earned through fuller seats — a structural condition that will determine how durable the July bump actually proves.
Streaming's Maturation, Theatrical's Argument
For readers who care about cinema as art and not just a ledger line, the structural context matters. OTT — the industry's shorthand for streaming — is forecast to grow at a 6.1% CAGR through 2030, but PwC's outlook warns of maturing markets in which "subscription fatigue" sets in, accelerating consolidation, bundling, and partnership activity. Meanwhile, advertising within streaming is projected to expand at a 9.4% CAGR, lifting its share of segment revenues from 19.4% today to 22.6% by 2030. Bart Spiegel, PwC's Global Entertainment & Media Sector Leader, frames the underlying logic with precision worth quoting at length: "Amid heightened industry competition and growing digital ecosystems, market players must be thinking about their service offerings — bundling packaged options for price conscious consumers, and providing tailored, in-person premium experiences that consumers continue to demand." That sentence — *in-person premium experiences* — is, for our purposes, the whole argument for theatrical exhibition in two words.
What We Are Actually Watching
The question we keep returning to as the marquees fill in is not whether the box office will recover but whether the recovery is producing the films worth recovering for. A crowded slate can lift annual totals on sheer volume and pricing power; it cannot, on its own, restore the cultural urgency cinema once commanded. We will be tracking the calendar not for its commercial arithmetic but for its editorial signal — which directors studios are trusting with their flagship releases, and whether smaller, more adventurous work is still being given room to breathe alongside the tentpoles. The numbers will tell us how the industry is performing. The programming will tell us what it believes in.